NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00470223,Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma,https://clinicaltrials.gov/study/NCT00470223,OS2006,ACTIVE_NOT_RECRUITING,"RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Zoledronic acid may stop the growth of tumor cells in bone. Giving chemotherapy with or without zoledronic acid before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving these treatments after surgery may kill any tumor cells that remain after surgery. It is not yet known whether giving combination chemotherapy together with zoledronic acid is more effective than combination chemotherapy alone in treating osteosarcoma.

PURPOSE: This randomized phase III trial is studying combination chemotherapy and zoledronic acid to see how well they work compared with combination chemotherapy alone in treating patients with osteosarcoma.",NO,Sarcoma,DRUG: cisplatin|DRUG: doxorubicin hydrochloride|DRUG: etoposide|DRUG: ifosfamide|DRUG: methotrexate|DRUG: zoledronic acid|PROCEDURE: conventional surgery,"Event-free survival, 3 years","Overall survival, 10 years|Percentage of good responders, at the time of the surgery|Short term and long term toxicity, 10 years",,UNICANCER,"Novartis|Chugai Pharmaceutical|National Cancer Institute, France|SFCE|Ligue contre le cancer, France",ALL,"CHILD, ADULT",PHASE3,318,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,Sarcome 09/0603|UNICANCER-SARCOME-09-0603|2006-003377-27,2007-03,2015-12,2026-12,2007-05-07,,2024-04-18,"Centre Paul Papin, Angers, 49036, France|Institut Gustave Roussy, Angers, 49036, France|Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besancon, 25030, France|CHR de Besancon - Hopital Saint-Jacques, Besancon, 25030, France|Institut Bergonie, Bordeaux, 33076, France|CHU Hopital A. Morvan, Brest, 29609, France|CHU de Caen, Caen, 14033, France|Centre Regional Francois Baclesse, Caen, 14076, France|CHR Clermont Ferrand, Hotel Dieu, Clermont-Ferrand, 63003, France|Centre Jean Perrin, Clermont-Ferrand, 63011, France|Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, 21079, France|Centre Hospitalier Universitaire de Dijon, Dijon, 21079, France|CHU de Grenoble - Hopital Michallon, Grenoble, 38043, France|Centre Oscar Lambret, Lille, 59020, France|Centre Leon Berard, Lyon, 69373, France|Hopital Edouard Herriot - Lyon, Lyon, 69437, France|Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille, 13273, France|CHU de la Timone, Marseille, 13385, France|Hopital d'Enfants de la Timone, Marseille, 13385, France|CHU Nord, Marseille, 13915, France|Hopital Arnaud de Villeneuve, Montpellier, 34295, France|Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, 34298, France|Centre Antoine Lacassagne, Nice, 06189, France|Hopital de l'Archet CHU de Nice, Nice, F-06202, France|Institut Curie Hopital, Paris, 75248, France|Hopital Jean Bernard, Poitiers, 86021, France|Centre Eugene Marquis, Rennes, 35042, France|Hopital Charles Nicolle, Rouen, 76031, France|Centre Henri Becquerel, Rouen, 76038, France|Institut de Cancerologie de la Loire, Saint Priest en Jarez, 42270, France|Centre Regional Rene Gauducheau, Saint-Herblain, 44805, France|Hopitaux Universitaire de Strasbourg, Strasbourg, 67091, France|Hopital Universitaire Hautepierre, Strasbourg, 67098, France|Hopital des Enfants, Toulouse, 31059, France|C.H. Bastien de Clocheville, Tours, 3700, France|CHRU de Tours - Hopital Trousseau, Tours, 37044, France|Centre Alexis Vautrin, Vandoeuvre-les-Nancy, 54511, France",
